Thalia Therapeutics Plc (AIM:THAT)
London
· Delayed Price · Currency is GBP · Price in GBX 0.550
-0.025 (-4.35%)
Apr 28, 2026, 1:46 PM GMT
Thalia Therapeutics Market Cap
Thalia Therapeutics has a market cap or net worth of 4.79 million as of April 28, 2026. Its market cap has increased by 137.40% in one year.
Market Cap
4.79M
Enterprise Value
3.06M
Revenue
7.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
Market Cap Chart
Since May 3, 2017, Thalia Therapeutics's market cap has increased from 4.57M to 4.79M, an increase of 4.68%. That is a compound annual growth rate of 0.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theracryf | 5.05M |
| OptiBiotix Health | 5.06M |
| Nuformix | 4.40M |
| CRISM Therapeutics | 6.73M |
| Futura Medical | 7.70M |
| BSF Enterprise | 2.92M |
| Cizzle Biotechnology Holdings | 8.32M |
| Oxford BioDynamics | 9.44M |